News

BTIG Maintains a Buy Rating on Novavax (NVAX), Sets a $19 PT
Novavax Inc. (NASDAQ:NVAX) is one of the best cheap stocks with huge upside potential. On June 11, BTIG maintained a Buy ...
Despite Revenue Jump, Novavax Appears Immune To Long-Term Growth
Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...
Citi Initiates Coverage of Novavax (NVAX) With a Sell Rating
Novavax Inc. (NASDAQ:NVAX) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On June 17, Citi initiated ...
13 Cheap Stocks with Huge Upside Potential
He stated that the episode of the last six months showed just how brutally efficient the price discovery process is, in any ...
POET Technologies (POET) Announces Intention to Complete Offering
POET Technologies Inc. (NASDAQ:POET) is one of the 10 Best Semiconductor Stocks to Buy According to Reddit. The company ...
Novavax Inc. stock underperforms Friday when compared to competitors
Novavax Inc. closed 61.59% short of its 52-week high of $17.81, which the company achieved on July 26th.
Zacks Investment Research on MSN6d
Novavax (NVAX) Dips More Than Broader Market: What You Should Know
Novavax (NVAX) closed the most recent trading day at $6.61, moving -2.79% from the previous trading session. The stock fell short of the S&P 500, which registered a loss of 0.79% for the day. At the ...
FDA's Prasad overruled agency scientists in restricting use of COVID shots - report
The leader of the U.S. FDA's division that oversees vaccines, Vinay Prasad, overruled the recommendations of his agency's ...
Hosted on MSN20d
Moderna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?
and Novavax Inc. (NASDAQ: NVAX). Moderna is the leader in messenger ribonucleic acid (mRNA) technology. mRNA medicines carry genetic blueprints to ribosomes in cells to produce therapeutic proteins ...